4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-009714
President and CEO sold 706 shares at $10.51 ($7,420)
From the SEC's structured data for this filing
Trades in this filing
AHMED NADIM · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-23 | Sale : show line 1 in the form | −706 | $10.51 | $7,420 | 118,004 | D |
| Open-market sales · 706 sh · avg $10.51 · $7,420 | ||||||
Loading xslF345X04/doc4.xml…